Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NANOMIX Corp | Interim CFO, Director | Common Stock | 1.7M | $424K | $0.25 | Nov 30, 2022 | Direct |
NANOMIX Corp | Interim CFO, Director | Incentive Stock Option (right to buy) | 1.7M | Nov 30, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NNMX | NANOMIX Corp | Dec 1, 2022 | 2 | $2.45K | 4 | Dec 16, 2022 | Interim CFO, Director |
NNMX | Boston Therapeutics, Inc. | Jun 4, 2021 | 0 | $0 | 3 | Jun 29, 2021 | CEO and President, Director |